MARINUS PHARMACEUTICALS INC's ticker is and the CUSIP is 56854Q200. A total of 74 filers reported holding MARINUS PHARMACEUTICALS INC in Q2 2022. The put-call ratio across all filers is 1.41 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $41,007 | -83.6% | 5,094 | -77.9% | 0.00% | -100.0% |
Q2 2023 | $249,878 | -30.5% | 23,009 | -55.8% | 0.00% | 0.0% |
Q1 2023 | $359,442 | +3485.1% | 52,093 | +1968.0% | 0.00% | – |
Q4 2022 | $10,026 | -87.3% | 2,519 | -78.9% | 0.00% | – |
Q3 2022 | $79,000 | +113.5% | 11,912 | +56.5% | 0.00% | – |
Q2 2022 | $37,000 | -83.5% | 7,612 | -68.3% | 0.00% | – |
Q1 2022 | $224,000 | -42.0% | 23,977 | -26.2% | 0.00% | – |
Q4 2021 | $386,000 | +33.6% | 32,477 | +27.9% | 0.00% | – |
Q3 2021 | $289,000 | +5680.0% | 25,387 | +9855.7% | 0.00% | – |
Q2 2021 | $5,000 | -97.8% | 255 | -98.3% | 0.00% | – |
Q1 2021 | $227,000 | -40.1% | 14,691 | -52.7% | 0.00% | -100.0% |
Q4 2020 | $379,000 | +0.8% | 31,056 | +6.1% | 0.00% | 0.0% |
Q3 2020 | $376,000 | – | 29,274 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Lion Point Capital, LP | 3,629,622 | $33,936,000 | 7.88% |
VR Adviser, LLC | 3,156,803 | $29,516,000 | 4.78% |
Bleichroeder LP | 1,322,463 | $12,365,000 | 2.19% |
Bain Capital Life Sciences Investors, LLC | 1,431,058 | $13,380,000 | 1.30% |
683 Capital Management, LLC | 1,932,829 | $18,072,000 | 0.97% |
Granite Point Capital Management, L.P. | 472,056 | $4,414,000 | 0.92% |
SUVRETTA CAPITAL MANAGEMENT, LLC | 2,766,000 | $25,862,000 | 0.79% |
Avoro Capital Advisors LLC | 3,150,000 | $29,453,000 | 0.54% |
Artal Group S.A. | 1,000,000 | $9,350,000 | 0.39% |
Stonepine Capital Management, LLC | 56,747 | $531,000 | 0.22% |